Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01070121 · ClinicalTrials.gov registry record
Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository
A clinical trial of Rheumatoid Arthritis, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 200
- Enrollment target
- 9
- Study locations
NCT01070121: Completed study of Rheumatoid Arthritis, sponsored by University of Alabama at Birmingham.
NCT01070121 is a study of Rheumatoid Arthritis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01070121, a study of Rheumatoid Arthritis, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 9
- Study locations
Study Summary
To stimulate collaborative efforts of federal funding agencies, voluntary health agencies, professional organizations and industry partners to enable creation of a large, sustainable database and repository to better understand the molecular basis of treatment and rapidly accelerate translational research in RA.
Conditions Studied
Study Locations (9)
Alabama
- University of Alabama at Birmingham - Birmingham
California
- Stanford University - Palo Alto
Colorado
- University of Colorado in Denver - Aurora
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Brigham and Women's Hospital - Boston
Nebraska
- University of Nebraska Medical Center - Omaha
New York
- North Shore Medical Center (LIJ Health System) - Lake Success
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-08 |
What the finished NCT01070121 record still lists
NCT01070121 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT01070121 lists 9 locations in 9 states (Alabama, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT01070121 about?
NCT01070121 is a clinical study titled "Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository". To stimulate collaborative efforts of federal funding agencies, voluntary health agencies, professional organizations and industry partners to enable creation of a large, sustainable database and repository to better understand the molecular basis of treatment and rapidly accelerate translational re...
What is the current status of trial NCT01070121?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2010-02. Estimated completion is 2012-08.
What conditions does trial NCT01070121 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis.
Who is sponsoring clinical trial NCT01070121?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01070121 being conducted?
This trial has 9 study locations across Alabama, California, Colorado, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01070121's enrollment target sits among peer trials
200 84th of 197 higher than 110 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia